Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.
Keith Josephs talks about considering TDP-43 as a potential factor related to increased rates of hippocampal atrophy in patients with Alzheimer's disease.
Cathy Stinear discusses her review of biomarkers that might predict motor recovery after stroke.
Lesley Jones and Sarah Tabrizi talk about their work on the identification of genetic markers associated with the progression of Huntington's disease.
Jeremy Chataway discusses the surprising effects of simvastatin on patients with secondary progressive multiple sclerosis.
Adam Boxer offers an overview of the latest on diagnosis and treatment for progressive supranuclear palsy.
Eva Feldman discusses the neurological consequences of obesity.
Marc Diamond discusses his Personal View on the prion model for progression and diversity of neurodegenerative diseases.
Randall Bateman and Nick Fox discuss what they've learned from their papers on Alzheimer's disease.
Professor Thomas Similowski discusses his surprising study on the effectiveness of non-invasive ventilation for patients with amyotrophic lateral sclerosis.
Dr. Kiran Maski discusses insomnia, parasomnia, and narcolepsy in children.
Dr. Gustavo Saposnik discusses the efficacy of non-immersive virtual reality exercise in the treatment of stroke.
Professor Valery Feigin discusses an Article on the global burden of stroke and risk factors from 1990–2013.
Annemieke Aartsma-Rus and Elizabeth Vroom discuss with Patricia Lobo the developments in Duchenne muscular dystrophy therapy and how this can serve as a paradigm for development of treatment for rare diseases.
Richard Lane interviews John Hardy, Jonathan Rohrer and Sarah Tabrizi, who are members of the Scientific Committee.
Francesc Graus and Josep Dalmau discuss new criteria for a clinical approach for the diagnosis of autoimmune encephalitis.
Rustam Salman discusses how the assessment of cerebral cavernous malformations can help identify people at risk of subsequent brain haemorrhage.
Bas Bloem talks about ParkinsonNet, a healthcare model that supports a multidisciplinary network for people with Parkinson’s disease.
Clifford Jack from the Mayo Clinic discusses a research article which investigates the role of biomarkers to help identify preclinical dementia.
Chris McDermott and Richard Lane discuss the DiPALS study, investigating the effect of diaphragm pacing in addition to non-invasive ventilation in patients with ALS.
© 2009-2013 Ebling Library, UW-Madison
750 Highland Ave, Madison, WI, 53705-2221